This supplement includes 3 additional articles ... analysis of the combined use of alpha-blockers and 5-alpha reductase inhibitors to treat EP. The final article compares medical costs incurred ...

Compared to placebo treatment, taking 5-alpha-reductase inhibitors (5-ARIs) can reduce a man's risk of being diagnosed with prostate cancer from around 5--9 percent to around 4-6 percent during up ...

To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological ...

Back to Healio A recent study found prior use of 5-alpha-reductase inhibitors for benign prostatic hyperplasia was associated with delayed prostate cancer diagnosis and worse prostate cancer outcomes.

Back to Healio While 5-alpha-reductase inhibitor use did not increase the risk of suicide in older men, it did increase the risk of self-harm and depression compared with men who were unexposed to ...

Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men but risks for self-harm and depression were increased during the 18 months after medication ...

including 5-alpha reductase inhibitors such as finasteride (Proscar), which shrink the prostate gland. In the US, no herbal supplement is approved as BPH treatment. The American Urological ...

You can ask your doctor about medications, supplements, and even watchful ... Of the several kinds of phosphodiesterase-5 inhibitors, the FDA has approved only tadalafil (Cialis) to treat BPH.

Compared to placebo treatment, taking 5-alpha-reductase inhibitors (5-ARIs) can reduce a man’s risk of being diagnosed with prostate cancer from around 5–9% to around 4-6% during up to 7 years ...